The VAC4EU Journal Club is a monthly appointment for members of VAC4EU and for its community. Its purpose is to share the common passion and curiosity for vaccine research. The Journal Club is fun! It is not a moment when we speak about deadlines, or about own work, but it’s a place to share open questions, and even doubts, and progress in our understanding on interesting topics thanks to the interaction with each other: it is a place where we are not afraid that our questions are too naive.
During the Journal Club, a speaker presents a published paper of his or her choice. The paper may cover any topic related to vaccine research, from methodological issues, to results of relevance, to curious findings. The speaker is free to take the opportunity of the Journal Club to better understand a paper with the help of the critical discussion with the audience: the conversation is highly interactive, open and informal!
You will receive a periodic invitation to register to the next appointment.
If you wish to volunteer to speak at the VAC4EU Journal Club, please send a message to firstname.lastname@example.org
The VAC4EU Journal Club is:
An appointment where we share our passion for vaccine research
A place where we share curiosity
A place where we share questions and doubts, and look together for answers
The VAC4EU Journal Club is not:
A place to disseminate our work
A work appointment
29th July, 3-4pm CEST
Sophie Bots, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands will speak about: Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med. 2006 May 30;25(10):1768–97.
To join the meeting, please click the Register button
Nicolas Thurin, BPE, Universite de Bordeaux, France will speak about:
Wang S et al, A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record Data, Clinical Epidemiology. 2022.
27th May, 3-4pm CEST
Lin Li, Sanofi, France will speak about:
Wang SV, Abdurrob A, Spoendlin J, Lewis E, Newcomer SR, Fireman B, Daley MF, Glanz JM, Duffy J, Weintraub ES, Kulldorff M. Methods for addressing “innocent bystanders” when evaluating safety of concomitant vaccines. Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):405-412. doi: 10.1002/pds.4399.
29th April, 3-4pm CEST
Rosa Gini, ARS Toscana (Italy) spoke about:
“Sullivan S et al, Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness, Am J Epidemiol. 2016.”
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.